Drug Profile
TEI 9826
Alternative Names: Free acid of TOK 4528; Lipo-TEI 9826Latest Information Update: 19 Oct 2000
Price :
$50
*
At a glance
- Originator Teijin Pharma
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Oct 2000 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 20 Jun 2000 A preclinical study has been added to the adverse events, pharmacokinetics and Cancer pharmacodynamics sections
- 24 Feb 2000 A preclinical study has been added to the pharmacokinetics and Cancer pharmacodynamics sections